US Stock MarketDetailed Quotes
CLOV Clover Health
- 3.230
- +0.040+1.25%
Close Dec 20 16:00 ET
- 3.210
- -0.020-0.62%
Post 20:01 ET
1.62BMarket Cap-17.94P/E (TTM)
3.295High3.125Low5.16MVolume3.150Open3.190Pre Close16.67MTurnover1.30%Turnover RatioLossP/E (Static)501.11MShares4.71052wk High4.73P/B1.28BFloat Cap0.60652wk Low--Dividend TTM396.04MShs Float28.850Historical High--Div YieldTTM5.33%Amplitude0.606Historical Low3.231Avg Price1Lot Size
Clover Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.16%330.99M | 11.28%356.26M | 7.74%346.92M | -41.50%2.03B | 20.78%1.09B | -64.28%306.03M | -62.19%320.14M | -63.17%321.99M | 136.19%3.48B | 108.04%898.79M |
| Operating revenue | 7.09%322.58M | 11.30%349.9M | 7.77%341.72M | -42.02%2.01B | 20.54%1.08B | -64.69%301.23M | -62.83%314.38M | -63.68%317.09M | 136.19%3.47B | 107.81%892.86M |
| Cost of revenue | 5.93%249.77M | 1.67%248.35M | -3.50%265.16M | -48.57%1.78B | 14.31%1.02B | -71.92%235.79M | -71.56%244.26M | -68.11%274.79M | 122.67%3.45B | 102.21%893.65M |
| Gross profit | 15.62%81.21M | 42.22%107.91M | 73.21%81.76M | 1,031.88%257.33M | 1,143.88%64.01M | 312.76%70.24M | 727.80%75.88M | 272.94%47.2M | 128.71%22.74M | 152.01%5.15M |
| Operating expense | -11.71%90.54M | 0.24%100.25M | -16.77%104.11M | 11.57%440M | -0.12%112.35M | 12.55%102.55M | 10.33%100.01M | 24.92%125.09M | -29.30%394.38M | -36.41%112.49M |
| Selling and administrative expenses | -11.22%90.2M | -4.06%99.92M | -18.03%103.79M | -8.61%444.73M | -9.64%112.36M | -13.88%101.6M | -11.39%104.15M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M |
| -General and administrative expense | -11.22%90.2M | -4.06%99.92M | -18.03%103.79M | -8.61%444.73M | -9.64%112.36M | -13.88%101.6M | -11.39%104.15M | -0.13%126.63M | 9.17%486.64M | 9.00%124.35M |
| Depreciation amortization depletion | -39.14%339K | -66.97%330K | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K |
| -Depreciation and amortization | -39.14%339K | -66.97%330K | 13.98%318K | 111.37%2.51M | 180.14%674K | -9.58%557K | 70.48%999K | -66.22%279K | -4.74%1.19M | -199.17%-841K |
| Other operating expenses | ---- | ---- | ---- | 92.25%-7.24M | 93.80%-683K | 101.43%392K | 81.30%-5.14M | 93.41%-1.81M | -184.32%-93.45M | -117.78%-11.02M |
| Operating profit | 71.14%-9.32M | 131.74%7.66M | 71.31%-22.35M | 50.85%-182.67M | 54.97%-48.34M | 56.40%-32.3M | 76.51%-24.13M | 10.96%-77.89M | 41.66%-371.65M | 42.53%-107.34M |
| Net non-operating interest income expense | 0 | 0 | 99.49%-7K | 0 | 0 | 98.28%-7K | 91.94%-1.36M | 66.26%-139K | ||
| Non-operating interest expense | --0 | --0 | ---- | -99.49%7K | --0 | --0 | -98.28%7K | ---- | -91.94%1.36M | -66.26%139K |
| Other net income (expense) | 140.97%538K | 89.68%-490K | 54.62%-820K | -191.76%-30.69M | -198.12%-22.82M | -33.98%-1.31M | -287.12%-4.75M | -114.58%-1.81M | -49.44%33.44M | 23.26M |
| Gain on sale of security | ---- | ---17K | ---467K | -147.56%-4.81M | ---- | ---- | ---- | ---- | -84.71%10.12M | ---70K |
| Special income (charges) | 140.97%538K | 90.04%-473K | 80.46%-353K | -210.93%-25.88M | -177.19%-18.01M | ---1.31M | ---4.75M | ---1.81M | --23.33M | --23.33M |
| -Less：Restructuring and merger&acquisition | -140.97%-538K | -90.04%473K | -80.46%353K | --9.93M | --2.06M | --1.31M | --4.75M | --1.81M | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --15.95M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---23.33M | ---- |
| Income before tax | 73.87%-8.79M | 124.82%7.17M | 70.93%-23.17M | 37.17%-213.36M | 15.52%-71.16M | 55.47%-33.62M | 72.32%-28.89M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M |
| Income tax | ||||||||||
| Net income | 77.92%-9.16M | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M |
| Net income continuous Operations | 73.87%-8.79M | 124.82%7.17M | 70.93%-23.17M | 37.17%-213.36M | 15.52%-71.16M | 55.47%-33.62M | 72.32%-28.89M | -5.57%-79.7M | 42.23%-339.57M | 55.01%-84.23M |
| Net income discontinuous operations | 95.29%-370K | 217.33%238K | -43.60%4M | ---- | ---- | ---7.85M | --75K | --7.09M | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 77.92%-9.16M | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 77.92%-9.16M | 125.71%7.41M | 73.60%-19.17M | 37.17%-213.36M | 16.33%-70.47M | 45.07%-41.47M | 72.39%-28.81M | 3.82%-72.61M | 42.23%-339.57M | 55.01%-84.23M |
| Basic earnings per share | 77.78%-0.02 | 116.67%0.01 | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 |
| Diluted earnings per share | 77.78%-0.02 | 116.67%0.01 | 75.00%-0.04 | 38.03%-0.44 | 16.80%-0.1463 | 43.75%-0.09 | 72.73%-0.06 | 0.00%-0.16 | 50.00%-0.71 | 55.77%-0.1759 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data